Kyverna Therapeutics reposted this
Kyverna Villagers just got an energy boost this summer - our 2024 interns support and learn about our efforts in bringing cell therapy to patients with autoimmune disease.
Skip to main content
Kyverna Therapeutics reposted this
Kyverna Villagers just got an energy boost this summer - our 2024 interns support and learn about our efforts in bringing cell therapy to patients with autoimmune disease.
To view or add a comment, sign in
We were thrilled to have Karen Walker represent Kyverna on the panel discussion “Accelerating Access to Cell Therapies – Streamlining Research Translation and Expedited Manufacturing Technologies" at #MeetingOnTheMesa this week.
To view or add a comment, sign in
Over the weekend, Kyverna proudly supported the 2024 Walk to End Lupus Now in New York City. It was an inspiring event by Lupus Foundation of America, Inc., bringing together patients, caregivers and advocates - all united by a shared mission to make a difference for the lupus community. We're excited to continue our involvement at the San Francisco walk later this month!
To view or add a comment, sign in
Thrilled to partner with ElevateBio in developing a paradigm shift in the treatment of patients living with B cell-driven autoimmune disease. #cartcelltherapy
Kyverna Therapeutics is seeking to revolutionize the way patients with autoimmune disease are treated by leveraging ElevateBio BaseCamp’s expertise in process development and cell product manufacturing. Learn more about the strategic partnership at https://bit.ly/3N6VEVH.
To view or add a comment, sign in
We are excited to present case reports from our ongoing #cartcelltherapy trials in #stiffpersonsyndrome, #myastheniagravis, and #multiplesclerosis during our symposium at #ECTRIMS2024, together with posters on KYSA-6 and KYSA-7 study design. Read more in our press release here: https://lnkd.in/gcaMUEpN
To view or add a comment, sign in
Excited to present our latest data this Wednesday at #ECTRIMS2024 and advance the knowledge on the potential of #cartcelltherapy in neurologic #autoimmunedisease.
To view or add a comment, sign in
Today, we are excited to welcome Warner Biddle as our Chief Executive Officer. With over 30 years of global experience in senior and franchise leadership roles, Warner has an outstanding track record of steering #biotech companies through pivotal growth phases and transformative milestones. Warner’s leadership and extensive industry knowledge will be instrumental as he leads us through our next stage of growth as our clinical-stage programs in #cartcelltherapy and #autoimmunediseases continue to advance. Welcome to the team, Warner! Read more in our press release: https://lnkd.in/gxi2bWkf
To view or add a comment, sign in
Proud to have our President, Research and Development, Dominic Borie, M.D., Ph.D. presenting at the 13th HUHRD (Hanyang University Hospital for Rheumatic Diseases) International Symposium to advance the knowledge around #cartcelltherapy in the treatment of #autoimmunedisease. For more information: https://lnkd.in/gvhsdvum #KYV101 #AskKyverna
To view or add a comment, sign in
Proud to have been the 'Featured Presenter' at the Cell Therapy Manufacturing session during the 16th Annual Bioprocessing Summit in Boston last week. The event brought together leaders from industry and academia, where our clinical product data saw significant interest. #CARTCellTherapy #KYV101
To view or add a comment, sign in
Thank you Shamekka Marty PMP, CSM for being a voice for the voiceless and a fierce advocate for patient and caregiver education about potential shifts in the treatment paradigm for #autoimmunedisease. It was a pleasure hosting you at the Village.
2023 Sequioa Project Patient Volunteer of the Year| Cybersecurity Project Manager| Certified Scrum Master| Healthcare Interoperability | Patient Advocate | Speaker | Connector | Agent of change
Thank you, Kyverna Therapeutics, for the opportunity to speak with you today about my experiences living with #lupus. It's vital that we work together to reach more individuals and change the stigma surrounding clinical trials for #CAR T-cell therapy, as well as the importance of patient informed consent in regards to wearable devices. I truly appreciate the leadership within your company for engaging with #patient advocates; it shows a commitment to understanding our community's needs. I'm excited to see how dedicated your team is to improving treatments for lupus and exploring the possibility of a cure. I look forward to learning more about the studies on CAR T-cell therapy and its impact on #autoimmune diseases. #cartcelltherapy #lupus #autoimmunedisease #ms #scleraderma #patientadvocate #informedconsent
To view or add a comment, sign in
Pleased to share we have received our second U.S. FDA RMAT Designation for #KYV101 in the treatment of patients with progressive myasthenia gravis. The application was evaluated based on the positive clinical outcomes in patients treated in Germany under the named-patient program. The Regenerative Medicine Advanced Therapies designation allows Kyverna to leverage more expedited meetings and more senior FDA leadership involvement throughout the development cycle for KYV-101. #myastheniagravis #cartcelltherapy https://lnkd.in/g7J3AQ5x
To view or add a comment, sign in
16,396 followers
Create your free account or sign in to continue your search
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.